Severe Hemophilia A: Clinical Trials

4 trials for Severe Hemophilia A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Active not recruiting 1, Recruiting 1

Follow Severe Hemophilia A: new trials by email Literature Review of Severe Hemophilia A trials Research Report on Severe Hemophilia A

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Nuwiq - Severe Hemophilia A
Phase 4RecruitingOctapharma282023-11-282026-05-12
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
Emicizumab - Severe Hemophilia A, Moderate Hemophilia A
Phase 4Active not recruitingHoffmann-La Roche1362022-06-202026-10-23
Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Alphanate SD/HT - Severe Hemophilia A
Phase 4CompletedGrifols Biologicals, LLC512003-04-082025-01-16
Canadian Hemophilia Prophylaxis Study
Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS) - Severe Hemophilia A
Phase 4CompletedThe Hospital for Sick Children561997-06-262019-12-05

Narrower conditions

Hemophilia A (4)

Broader conditions

Blood Coagulation Disorders (4)  ·  Blood Coagulation Disorders, Inherited (4)  ·  Coagulation Protein Disorders (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemorrhagic Disorders (4)

Interventions

Factor VIII (3)  ·  emicizumab (1)

Sponsors

Grifols Biologicals, LLC (1)  ·  Hoffmann-La Roche (1)  ·  Octapharma (1)  ·  The Hospital for Sick Children (1)

Countries

Canada (2)  ·  Germany (2)  ·  Italy (2)  ·  Serbia (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Brazil (1)  ·  Croatia (1)  ·  Finland (1)  ·  France (1)  ·  Hungary (1)  ·  India (1)  ·  Morocco (1)  ·  North Macedonia (1)

Top investigators

Brian M Feldman, MD (1)  ·  Michael Ken Woodward (1)  ·  Shveta Gupta, MD (1)

Results publications

PMID 29731369, PMID 41151952

NIH funding

2023 (1)